HomeCGTX • NASDAQ
add
Cognition Therapeutics Inc
Previous close
$0.44
Day range
$0.41 - $0.45
Year range
$0.35 - $2.95
Market cap
17.16M USD
Avg Volume
554.11K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
.INX
0.35%
3.22%
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 14.46M | -1.91% |
Net income | -9.94M | -47.24% |
Net profit margin | — | — |
Earnings per share | -0.25 | -13.64% |
EBITDA | -14.44M | 1.93% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 22.01M | -33.24% |
Total assets | 27.58M | -28.87% |
Total liabilities | 13.10M | 33.02% |
Total equity | 14.48M | — |
Shares outstanding | 41.55M | — |
Price to book | 1.26 | — |
Return on assets | -116.73% | — |
Return on capital | -186.00% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -9.94M | -47.24% |
Cash from operations | -6.85M | -64.65% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 329.00K | 11,066.67% |
Net change in cash | -6.52M | -54.51% |
Free cash flow | -6.81M | -7.69% |
About
Founded
Jan 1, 2007
Headquarters
Website
Employees
25